Iodixanol: Risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations

被引:16
作者
Cheruvu, Bharadwaj [1 ]
Henning, Kathleen [1 ]
Mulligan, Janine [1 ]
Klippenstein, Donald [1 ]
Lawrence, David [1 ]
Gurtoo, Lalit [1 ]
Gottlieb, Ronald H. [1 ]
机构
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
关键词
computed tomography; contrast-induced nephropathy;
D O I
10.1097/rct.0b013e31802e29d9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: To assess the risk of contrast-induced nephropathy in cancer patients with underlying renal insufficiency receiving the iso-osmolar intravenous contrast agent iodixanol for diagnostic computed tomography (CT) examinations. Methods: Institutional review board approval was obtained with waiver of informed consent. Our study was a retrospective evaluation comparing the incidence of contrast-induced nephropathy in consecutive patients with underlying renal insufficiency undergoing diagnostic CT examinations receiving iodixanol from November 2003 to June 2005 with a comparison group of patients with normal baseline renal function over the same period. Renal insufficiency was considered a serum creatinine level more than 1.2 mg/dL in females and more than 1.5 mg/dL in males. Contrast nephropathy was considered an absolute elevation of 0.5 mg/dL or 25% elevation in serum creatinine level. Results: In the group of patients receiving iodixanol with underlying renal insufficiency (189 patients), 9.0% developed contrast nephropathy (P = 0.015) with 4.8% of patients developing irreversible renal damage (P = 0.03). This compared with 4.9% of patients receiving iodixanol (185 patients) and 3.1% of patients receiving iohexol (194 patients) with normal baseline renal function developing contrast nephropathy (P = 0.38) with 3.2% of the iodixanol patients and 1.0% of the iohexol patients developing irreversible renal damage (P = 0.13). Conclusions: The risk of contrast-induced nephropathy is significantly higher in patients with underlying renal insufficiency receiving iodixanol than that for patients with normal baseline renal function, but this should not serve as an absolute contraindication for these patients to receive intravenous iodinated contrast for diagnostic CT examinations particularly in patients with life-threatening clinical questions in which contrasted CT may provide valuable information.
引用
收藏
页码:493 / 498
页数:6
相关论文
共 36 条
[1]   Comparison of outcomes in men versus women having percutaneous coronary interventions in small coronary arteries [J].
Ashby, DT ;
Mehran, R ;
Aymong, EA ;
Lansky, AJ ;
Iakovou, I ;
Weisz, G ;
New, G ;
Moussa, I ;
Dangas, G ;
Moses, JW ;
Stone, GW ;
Leon, MB .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (08) :979-981
[2]   Nephrotoxic effects in high-risk patients undergoing angiography. [J].
Aspelin, P ;
Aubry, P ;
Fransson, S ;
Strasser, R ;
Willenbrock, R ;
Berg, KJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (06) :491-499
[3]   RADIOCONTRAST MEDIUM-INDUCED DECLINES IN RENAL-FUNCTION - A ROLE FOR OXYGEN FREE-RADICALS [J].
BAKRIS, GL ;
LASS, N ;
GABER, AO ;
JONES, JD ;
BURNETT, JC .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (01) :F115-F120
[4]   CONTRAST NEPHROPATHY IN PATIENTS WITH IMPAIRED RENAL-FUNCTION - HIGH VERSUS LOW OSMOLAR MEDIA [J].
BARRETT, BJ ;
PARFREY, PS ;
VAVASOUR, HM ;
MCDONALD, J ;
KENT, G ;
HEFFERTON, D ;
ODEA, F ;
STONE, E ;
REDDY, R ;
MCMANAMON, PJ .
KIDNEY INTERNATIONAL, 1992, 41 (05) :1274-1279
[5]   Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification [J].
Bartholomew, BA ;
Harjai, KJ ;
Dukkipati, S ;
Boura, JA ;
Yerkey, MW ;
Glazier, S ;
Grines, CL ;
O'Neill, WW .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (12) :1515-1519
[6]   Use of iso-osmolar nonionic dimeric contrast media in multidetector row computed tomography angiography for patients with renal impairment [J].
Becker, CR ;
Reiser, MF .
INVESTIGATIVE RADIOLOGY, 2005, 40 (10) :672-675
[7]   Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trial [J].
Carraro, M ;
Malalan, F ;
Antonione, R ;
Stacul, F ;
Cova, M ;
Petz, S ;
Assante, M ;
Grynne, B ;
Haider, T ;
Dalla Palma, L ;
Faccini, L .
EUROPEAN RADIOLOGY, 1998, 8 (01) :144-147
[8]   Comparison of iodixanol and iohexol in renal impairment [J].
Chalmers, N ;
Jackson, RW .
BRITISH JOURNAL OF RADIOLOGY, 1999, 72 (859) :701-703
[9]   PREDICTING ANGIOGRAPHY-INDUCED ACUTE RENAL-FUNCTION IMPAIRMENT - CLINICAL RISK MODEL [J].
COCHRAN, ST ;
WONG, WS ;
ROE, DJ .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1983, 141 (05) :1027-1033
[10]   Preventing contrast nephropathy: What is the best strategy? - A review of the literature [J].
Cox, CD ;
Tsikouris, JP .
JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (04) :327-337